ACT Brief: Latest Developments in Clinical Research
In this episode of the Applied Clinical Trials Brief, we discuss key developments in clinical research operations, including the industry's push to reduce site technology burden.
AstraZeneca's Immunotherapy Advance
AstraZeneca's MATTERHORN trial has shown broad survival gains, reinforcing a major advance in immunotherapy.
Thermo Fisher's Acquisition of Clario
Thermo Fisher's $8.8 billion acquisition of Clario is set to advance AI-driven clinical research, signaling a new phase for digital trials.
Author's summary: Clinical research operations are evolving rapidly.